The cell entry receptor for SARS-CoV-2 is angiotensin-converting enzyme 2 (ACE2), and previous research has indicated that NSAIDs upregulate this enzyme, thus raising concerns that NSAIDs may increase vulnerability to infection [25,26]. The gene discussed is ACE2; the disease is infection.